BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31776736)

  • 1. Narrower QRS may be enough to respond to cardiac resynchronization therapy in lightweight patients.
    Nakai T; Mano H; Ikeya Y; Aizawa Y; Kurokawa S; Ohkubo K; Nagashima K; Watanabe I; Okumura Y
    Heart Vessels; 2020 Jun; 35(6):835-841. PubMed ID: 31776736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial.
    Varma N; Sogaard P; Bax JJ; Abraham WT; Borer JS; Dickstein K; Singh JP; Gras D; Holzmeister J; Brugada J; Ruschitzka F
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29807890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved patient selection for cardiac resynchronization therapy by normalization of QRS duration to left ventricular dimension.
    Zweerink A; Wu L; de Roest GJ; Nijveldt R; de Cock CC; van Rossum AC; Allaart CP
    Europace; 2017 Sep; 19(9):1508-1513. PubMed ID: 27707784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjusting the QRS Duration by Body Mass Index for Prediction of Response to Cardiac Resynchronization Therapy: Does One QRS Size Fit All?
    Karaca O; Omaygenc MO; Cakal B; Cakal SD; Gunes HM; Olgun E; Ibisoglu E; Savur U; Gokdeniz T; Boztosun B; Kilicaslan F
    Ann Noninvasive Electrocardiol; 2016 Sep; 21(5):450-9. PubMed ID: 26820486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QRS frequency characteristics help predict response to cardiac resynchronization in left bundle branch block less than 150 milliseconds.
    Niebauer MJ; Rickard J; Polakof L; Tchou PJ; Varma N
    Heart Rhythm; 2014 Dec; 11(12):2183-9. PubMed ID: 25068573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.
    Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F
    Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine Learning of 12-Lead QRS Waveforms to Identify Cardiac Resynchronization Therapy Patients With Differential Outcomes.
    Feeny AK; Rickard J; Trulock KM; Patel D; Toro S; Moennich LA; Varma N; Niebauer MJ; Gorodeski EZ; Grimm RA; Barnard J; Madabhushi A; Chung MK
    Circ Arrhythm Electrophysiol; 2020 Jul; 13(7):e008210. PubMed ID: 32538136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-Specific Response to Cardiac Resynchronization Therapy: Effect of Left Ventricular Size and QRS Duration in Left Bundle Branch Block.
    Varma N; Lappe J; He J; Niebauer M; Manne M; Tchou P
    JACC Clin Electrophysiol; 2017 Aug; 3(8):844-853. PubMed ID: 29759781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probability and magnitude of response to cardiac resynchronization therapy according to QRS duration and gender in nonischemic cardiomyopathy and LBBB.
    Varma N; Manne M; Nguyen D; He J; Niebauer M; Tchou P
    Heart Rhythm; 2014 Jul; 11(7):1139-47. PubMed ID: 24704570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Size Matters: Normalization of QRS Duration to Left Ventricular Dimension Improves Prediction of Long-Term Cardiac Resynchronization Therapy Outcome.
    Zweerink A; Friedman DJ; Klem I; van de Ven PM; Vink C; Biesbroek PS; Hansen SM; Emerek K; Kim RJ; van Rossum AC; Atwater BD; Nijveldt R; Allaart CP
    Circ Arrhythm Electrophysiol; 2018 Dec; 11(12):e006767. PubMed ID: 30541355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of QRS duration normalized to left ventricular volume for predicting cardiac resynchronization therapy efficacy in patients with "mid-range" QRS duration.
    Yamamoto N; Noda T; Nakano M; Ito T; Sato H; Hayashi H; Chiba T; Hasebe Y; Ueda N; Kamakura T; Ishibashi K; Miyata S; Kusano K; Yasuda S
    Heart Rhythm; 2024 Jun; 21(6):855-862. PubMed ID: 38367890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart Size Difference Drives Sex-Specific Response to Cardiac Resynchronization Therapy: A Post Hoc Analysis of the MORE-MPP CRT Trial.
    Wijesuriya N; Mehta V; De Vere F; Howell S; Niederer SA; Burri H; Sperzel J; Calo L; Thibault B; Lin W; Lee K; Grammatico A; Varma N; Gwechenberger M; Leclercq C; Rinaldi CA
    J Am Heart Assoc; 2024 Jun; 13(12):e035279. PubMed ID: 38879456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
    Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
    Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple electrophysiological predictor of QRS change induced by cardiac resynchronization therapy: A novel marker of complete left bundle branch block.
    Sedláček K; Jansová H; Vančura V; Grieco D; Kautzner J; Wichterle D
    Heart Rhythm; 2021 Oct; 18(10):1717-1723. PubMed ID: 34098086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QRS duration and QTc interval are predictors of risk for ventricular arrhythmias during cardiac resynchronization therapy.
    Prochnau D; Kuehnert H; Figulla HR; Surber R
    Acta Cardiol; 2011 Aug; 66(4):415-20. PubMed ID: 21894795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between QRS duration and resynchronization window for CRT optimization: Implications for CRT in narrow QRS patients.
    Harbin MM; Brown CD; Espinoza EA; Burns KV; Bank AJ
    J Electrocardiol; 2022; 72():72-78. PubMed ID: 35344747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LBBB and heart failure-Relationships among QRS amplitude, duration, height, LV mass, and sex.
    Manne M; Niebauer M; Tchou P; Varma N
    J Cardiovasc Electrophysiol; 2024 Mar; 35(3):583-591. PubMed ID: 37811553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular geometry-regularized QRSd predicts cardiac resynchronization therapy response: machine learning from crosstalk between electrocardiography and echocardiography.
    Lei J; Wang YG; Bhatta L; Ahmed J; Fan D; Wang J; Liu K
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1221-1229. PubMed ID: 31104177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of QRS Morphology and Duration on Clinical Outcomes After Cardiac Resynchronization Therapy - Analysis of Japanese Multicenter Registry.
    Oka T; Inoue K; Tanaka K; Hirao Y; Isshiki T; Kimura T; Nobuyoshi M; Shizuta S; Arita T; Fujii S; Iwakura K; Fujii K; Ando K
    Circ J; 2018 Jun; 82(7):1813-1821. PubMed ID: 29628460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. His-Optimized Cardiac Resynchronization Therapy to Maximize Electrical Resynchronization: A Feasibility Study.
    Vijayaraman P; Herweg B; Ellenbogen KA; Gajek J
    Circ Arrhythm Electrophysiol; 2019 Feb; 12(2):e006934. PubMed ID: 30681348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.